Eton Pharmaceuticals (ETON) Shares Outstanding (2017 - 2026)

Eton Pharmaceuticals has reported Shares Outstanding (Entity) for 9 years, with the latest figure at $27.0 million in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 1.27% year-over-year to $27.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $27.0 million (up 1.27% YoY) and the FY2025 annual result came in at $27.0 million, up 1.27% from the prior year.
• Shares Outstanding (Entity) rose to $27.0 million in Q4 2025 per ETON's latest filing, from $26.8 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $26.9 billion in Q2 2025 and troughed at $25126.0 in Q2 2022.
• A 5-year average of $1.4 billion and a median of $25.3 million in 2022 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) sank 99.9% in 2024, then jumped 104325293.75% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $24.6 million in 2021, then climbed by 2.95% to $25.4 million in 2022, then grew by 1.32% to $25.7 million in 2023, then gained by 3.97% to $26.7 million in 2024, then advanced by 1.27% to $27.0 million in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $27.0 million, $26.8 million, and $26.9 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.